MediWound (MDWD) Accumulated Depreciation & Amortization (2023)
MediWound (MDWD) recorded quarterly Accumulated Depreciation & Amortization of -$7.1 million in Q4 2023.
MediWound (MDWD) Accumulated Depreciation & Amortization (2023) Analysis & Trends
MediWound's Accumulated Depreciation & Amortization history runs 1 years deep, the most recent figure standing at -$7.1 million for Q4 2023.
- In Q4 2023, Accumulated Depreciation & Amortization changed N/A year-over-year to -$7.1 million; the TTM figure through Dec 2023 stood at -$7.1 million (changed N/A YoY), while the FY2023 annual figure was -$7.1 million, changed N/A from the prior year.
- Accumulated Depreciation & Amortization was -$7.1 million for Q4 2023 at MediWound.
- In the past five years, Accumulated Depreciation & Amortization ranged from a high of -$7.1 million in Q4 2023 to a low of -$7.1 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | MediWound | 3.70 Mn | 3.70 Mn | 278,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -7.14 Mn |
| Dec 31, 2023 | -7.14 Mn |